Category

R&D Institution

Scientific area(s)

Brief description

AIBILI is a Research Technology Organisation in the health area dedicated to the development and testing of new products for diagnostic imaging and medical therapy. It is a private non-profit organisation, founded in 1989, established to support translational research and technology transfer between academic institutions and the industry in the health area. Services provided: - Development and Coordination of Industry-Driven and Investigator-Driven Clinical Trials - Performance of Clinical Trials in ophthalmology and neurology (phase I, II, III and IV) - Development of new technologies – ophthalmology imaging - Reading Centre: Grading of color fundus photographs, OCT images of the retina and functional evaluations of the retina using mfERG - Control of raw material and pharmaceutical formulations during the manufacturing process or in the finished product - Bioavailability and pharmacokinetic studies - Pharmacotherapeutic and Pharmacoeconomic studies - Pharmacovigilance AIBILI is certified by ISO 9001:2008 for the activities of: research and development in new technologies for medicine with particular emphasis in the areas of imaging, optics and light; preclinical studies of new molecules of potential medical use; performance of clinical trials; performance of clinical pharmacology studies; planning, coordination, execution and monitoring of clinical research activities; and health technology assessment. Clinical trials are performed in accordance with ICH Guidelines for Good Clinical Practice (GCP) and the pharmacology studies are also developed in compliance with the OECD Principles of Good Laboratory Practice (GLP). AIBILI is the Coordinating Centre of the European Vision Institute Clinical Research Network – EVICR.net (www.evicr.net), that is a network of European Ophthalmological Clinical Research Sites, dedicated to perform clinical research in ophthalmology. AIBILI has been recognized in 2010 as a Champalimaud Translational Centre for Eye Research by the Champalimaud Foundation (C-TRACER) for its activities in translational eye research. Main goals of AIBILI are innovation and translational research that is to convert basic research knowledge into practical applications to enhance human health and wellbeing. It is important to realize that translational research has complementary domains: - the “bench to bedside” - translating knowledge from the basic sciences into the development of new treatments (basic research to clinical research) - translating the findings from clinical trials into everyday practice.

Website

http://www.aibili.pt

Mailing address

Azinhaga Sta. Comba, Celas

• Postal Code

  3000-548

• City

  Coimbra

Country

Portugal